期刊文献+

诺维苯联合顺铂治疗Ⅲb~Ⅳ期非小细胞肺癌60例临床观察 被引量:4

The Effects of Combined Chemotherapy Navelbine+Cisplatin in Tre atment of StageⅢb~ⅣNon-Small Cell Lung Cancer of 60Cases
下载PDF
导出
摘要 目的:比较去甲长春花碱(NVB)加顺铂(DDP)与环磷酰胺(CTX)、阿霉素(ADM)、顺铂(DDP)两个方案对Ⅲb~Ⅳ期复治的非小细胞肺癌的疗效。方法:随机将114例患者分为NVB组(60例),CAP组(54例),均化疗2个疗程,疗效评价按WHO疗效标准,总有效率以CR+PR计算。结果:总有效率NVB组45.0%,CAP组20.3%,χ2=6.69,P<0.01,两者差异显著。结论:对Ⅲb~Ⅳ期复治的非小细胞肺癌NVB+DDP联合化疗,疗效优于CAP方案。 objective:To compare the Curat ive effe ct of NP regimen(NVB+DDP)with that of CAP regimen(CTX+ADM+DDP)for stageⅢ b~Ⅳretreatment non-small cell lung cancer(NSCLC).Methods:114patients with NSCLC were randomly divided into NVB group(60cases)and CAP group(54c ases)Both were treated with chemotherapy for two courses of treatment.Ac-co rding to WHO's standard,the Curative effects were evaluated.Overall re sponse rates were cal-culated with CR+PR.Results:The overall reponse rates of NVB g roup and CAP group were45.0%and20.3%,respectively(÷ 2 =6.69,P<0.01).Conclusion:The cura tive effect of the regiment of NVB+DDP for combined chemotherapy for stageⅢb~Ⅳre treatment NSCLC is be tter than that of the CAP regimen.It's an effective first-line regimen for tre atment of non-small cell lung cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第1期29-30,共2页 Chinese Journal of Clinical Oncology
关键词 诺维苯 顺铂 治疗 非小细胞肺癌 疗效 临床分析 Lung cancer Retreated patient Navelbine+Cisplatin Curative effect
  • 相关文献

参考文献8

二级参考文献13

  • 1孙燕 周际昌.临床肿瘤内科手册(第三版)[M].北京:人民卫生出版社,1996.30-34.
  • 2肖秀兰,新药与临床,1995年,14卷,126页
  • 3宋三泰,医药卫生科学技术进展,1993年
  • 4管忠震,癌症,1993年,12卷,217页
  • 5张湘茹,北京医学,1992年,14卷,171页
  • 6张湘茹,中华肿瘤杂志,1998年,1卷,60页
  • 7Tan E H,Lung Cancer,1997年,17卷,Suppl2期
  • 8张湘茹,北京医学,1992年,14卷,171页
  • 9张明智,恶性肿瘤治疗新进展,1994年,275页
  • 10孙燕,临床肿瘤内科手册(第3版),1996年,371页

共引文献731

同被引文献18

  • 1[1]Fellous A, Meininger V, Binet S, et al. Action of nevelbin (NVB) on microtubules- role oftan and MAP2 proteins: Pierre fabre oncology. In: Mavelbine: Update and new trends. 1st ed. France: John Libbey Eurotest Ltd, 1991, 9
  • 2[2]Conroy T, Etienne PL, Adenis A, et al. vinorelbine (Navelbine): A promising drug in metastatic eoidermoid esophageal carcinoma. Proc Am Soc Clin, 1993, 12:A553
  • 3[3]Chevalier TL, Briggand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorellbine alone in advanced non-small-cell lung cancer:Results of a European multicencter trial including 612 patients.Clin Oncol, 1994, 12 (2) :360
  • 4[7]Faulds D. Current option in the treatment of non small cell lung cancer. Drugs, 1992, 44 (Suppl 4) :46
  • 5[8]Conroy T, Etienne PL, Adenis A, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus:Response, toxicity, quality of life and survival. Ann Oncol,2002, 13 (5) :721
  • 6Chevalier TL, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorebine alone in advanced non-small cell cancer: results of a European multicenter trial including612 patients [J]. Clin Oncology,1994,12(2):360-367.
  • 7管忠震 张力 张湘如.Nawdbline治疗晚期肺癌的临床研究报告[J].癌症,1995,12:217-217.
  • 8Johnson SA. Harper,p. Hertobagyi GN. et. viorelbine;an. Overview [ J ]. Cancer, Treatment Reviews, 1996,22 : 127.
  • 9Chevalier TL. Brisgend D. Douiuard. JY. et al. RandomJzed. study Of Vinorel bine and cisplatin versus, vindesine and Cisplatin versus vinorobine alone, in. advanced, non - smallcell canaer. Results of a, European mullicenter trid in cluding 612. patients [ J ]. clin oxeology, 1994,12 ( 2 ) :360 - 367,
  • 10孙燕.肺癌的发病、早期预防与早诊早治.中国医学论坛报,2004,30(47):13-13.

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部